Barnes M N, Landolt M L, Powell D B, Winton J R
School of Fisheries, University of Washington, Seattle 98195, USA.
Dis Aquat Organ. 1998 May 14;33(1):33-41. doi: 10.3354/dao033033.
Piscirickettsia salmonis is the etiological agent of salmonid rickettsial septicemia, an economically significant disease affecting the salmon aquaculture industry. As with other rickettsial pathogens, antigenic analysis of P. salmonis has been limited by the inherent difficulties of purifying an intracellular organism away from host cell material. In this report, we describe the use of diatrizoate meglumine and diatrizoate sodium (DMDS) density gradient centrifugation to purify P. salmonis grown in chinook salmonis was consistently concentrated in a visible band within the DMDS density gradient at density of 1.15 to 1.16 g ml(-1). Recovery of purified, viable organisms from DMDS density gradients varied from 0.6 to 3%. Preparations of uninfected CHSE-214 cells, CHSE-214 cells infected with P. salmonis, and gradient-purified P. salmonis were compared using sodium dodecyl sulfate polyacrylamide gel electrophoresis to assess the degree of purification and to identify P. salmonis-specific proteins. Although gradient-purified P. salmonis preparations were not completely free of host cell material, 8 bacterial proteins were identified. Polyclonal rabbit antiserum was used in an immunoblot of proteins from purified P. salmonis to identify 3 major and 5 minor antigens. The major antigens of 56, 30 and 20 kDa were potential candidates for experimental vaccines and development of novel diagnostic assays.
鲑鱼立克次氏体是鲑鱼立克次氏体败血症的病原体,这是一种对鲑鱼养殖业具有重大经济影响的疾病。与其他立克次氏体病原体一样,由于从宿主细胞材料中纯化细胞内生物体存在固有困难,对鲑鱼立克次氏体的抗原分析受到限制。在本报告中,我们描述了使用泛影葡胺和泛影酸钠(DMDS)密度梯度离心法来纯化在奇努克鲑鱼中生长的鲑鱼立克次氏体,其始终集中在DMDS密度梯度中密度为1.15至1.16 g/ml(-1)的可见带内。从DMDS密度梯度中回收纯化的活生物体的比例在0.6%至3%之间。使用十二烷基硫酸钠聚丙烯酰胺凝胶电泳对未感染的CHSE-214细胞、感染鲑鱼立克次氏体的CHSE-214细胞以及梯度纯化的鲑鱼立克次氏体进行制备物比较,以评估纯化程度并鉴定鲑鱼立克次氏体特异性蛋白质。尽管梯度纯化的鲑鱼立克次氏体制备物并非完全不含宿主细胞材料,但鉴定出了8种细菌蛋白质。使用兔多克隆抗血清对纯化的鲑鱼立克次氏体的蛋白质进行免疫印迹,以鉴定3种主要抗原和5种次要抗原。56 kDa、30 kDa和20 kDa的主要抗原是实验性疫苗和新型诊断检测方法开发的潜在候选物。